Risk of Radiation-Induced Cancer from Screening Mammography

Total Page:16

File Type:pdf, Size:1020Kb

Risk of Radiation-Induced Cancer from Screening Mammography Risk of Radiation-Induced Cancer from Screening Mammography Raed Mohammed Kadhim M. Ali School of Health Sciences UNIVERSITY OF SALFORD, SALFORD, UK Submitted in Partial Fulfillment of the Requirements of the Degree of Doctor of Philosophy, November 2016 (Medical Physics) Table of Contents List of Figures ....................................................................................................................... VII List of Tables .......................................................................................................................... X List of Publications, Conference Presentations and Seminars ...................................... XIII List of Training Sessions ................................................................................................... XIV Acknowledgements ................................................................................................................ XV Terminology........................................................................................................................ XVI List of Abbreviations ......................................................................................................... XVI Abstract .............................................................................................................................. XVIII Chapter One : Introduction and Thesis Outline ........................................................................ 1 1.1 Introduction ..................................................................................................................... 1 1.2 Rationale, Aim and Objectives........................................................................................ 1 1.3 Thesis Structure ............................................................................................................... 2 Chapter Two : Breast Anatomy, Cancer and Imaging Modalities ............................................ 6 2.1 Chapter Overview ........................................................................................................... 6 2.2 Breast Anatomy ............................................................................................................... 6 2.3 Breast Density ................................................................................................................. 9 2.3.1 Wolf Classification ................................................................................................. 10 2.3.2 Tabar Classification ................................................................................................ 10 2.3.3 BI-RADS Classification ......................................................................................... 10 2.3.4 Boyd Classification................................................................................................. 11 2.3.5 Summary ................................................................................................................. 11 2.4 Breast Cancer ................................................................................................................ 11 2.4.1 Breast Cancer Types ............................................................................................... 11 2.4.2 Breast Cancer Risk Factors ..................................................................................... 12 2.4.2.1 Unchangeable Risk Factors (Gender and Age) ............................................................ 12 2.4.2.2 Relationship of Cancer with Breast Density ................................................................. 12 2.4.2.3 Genetic Factors ............................................................................................................ 13 2.4.2.4 Other Factors ............................................................................................................... 13 2.4.3 Breast Cancer Statistics .......................................................................................... 14 2.5 Breast Imaging Modalities ............................................................................................ 15 I 2.5.1 Mammography........................................................................................................ 15 2.5.2 Breast Computed Tomography (BCT) ................................................................... 16 2.5.3 Breast Ultrasound ................................................................................................... 16 2.5.4 Breast Magnetic Resonance Imaging (MRI) .......................................................... 17 2.6 Breast Cancer Screening ............................................................................................... 18 2.6.1 Breast Self-Examination (BSE) .............................................................................. 18 2.6.2 Clinical Breast Examination (CBE) ....................................................................... 19 2.6.3 Mammography Screening....................................................................................... 19 2.6.4 Magnetic Resonance Imaging (MRI) Screening .................................................... 20 2.6.5 Ultrasound Screening ............................................................................................. 20 2.7 Chapter Summary .......................................................................................................... 20 Chapter Three : Mammography: Development, Physics and Clinical Aspects ...................... 21 3.1 Chapter Overview ......................................................................................................... 21 3.2 The Origins of Mammography Imaging – Equipment and Rudiments of Technique .. 22 3.2.1 Early Developments of Image Receptor ................................................................. 23 3.2.2 Dedicated Mammography Machine Development ................................................. 25 3.2.3 Mammography Developments during the 1980s and 1990s .................................. 26 3.3 Digital Mammography .................................................................................................. 27 3.3.1 Types of Digital Mammography Detectors ............................................................ 28 3.3.1.1 Computed Radiography (CR) ....................................................................................... 28 3.3.1.2 Indirect Digital Mammography .................................................................................... 29 3.3.1.3 Direct Digital Mammography ...................................................................................... 30 3.3.2 FFDM Performance ................................................................................................ 30 3.4 FFDM Physics and Instrumentation .............................................................................. 34 3.4.1 X-ray Tube .............................................................................................................. 34 3.4.2 Breast Compression Device .................................................................................... 37 3.4.3 Grid ......................................................................................................................... 40 3.4.4 Automatic Exposure Control (AEC) ...................................................................... 40 3.4.5 Generator ................................................................................................................ 41 3.4.6 Digital Mammographic Viewing Workstations ..................................................... 41 3.5 Digital Breast Tomosynthesis (DBT) ............................................................................ 42 II 3.5.1 DBT Physics and Instrumentation .......................................................................... 43 3.5.1.1 Image Acquisition ......................................................................................................... 43 3.5.1.2 DBT Image Reconstruction .......................................................................................... 45 3.5.2 Clinical Performance of DBT (for both diagnosis and screening) ......................... 46 3.6 Anatomical Characteristics of the Breast in Mammographic Images ........................... 49 3.6.1 Cranio-caudal (CC) Projection ............................................................................... 50 3.6.2 Medio-lateral Oblique (MLO) Projection ............................................................... 51 3.6.3 Supplementary Mammographic Projections .......................................................... 53 3.7 Screening Mammography ............................................................................................. 53 3.8 Chapter Summary .......................................................................................................... 61 Chapter Four : Mammography Dosimetry .............................................................................. 63 4.1 Chapter Overview ......................................................................................................... 63 4.2 Risk of Low Radiation Dose ......................................................................................... 64 4.3 Mammography Dosimetry ............................................................................................ 69 4.3.1 Mean Glandular Dose (MGD) ................................................................................ 70 4.3.2 Mammography: Dose to Organs Other
Recommended publications
  • 2. Screening Techniques
    2. SCREENING TECHNIQUES 2.1 X-ray techniques the contrast and the spatial resolution are poor, making detection of small lesions difficult. The The original technique for mammography mammogram in Fig. 2.1b, from the same era, is of was introduced by Salomon in Germany in 1913, much higher quality and illustrates a cancer seen 18 years after the discovery of X-rays by Roentgen on the basis of an irregularly shaped mass (black (Salomon, 1913). A mammogram is formed by arrow). Fig. 2.1c shows a digital mammogram, recording the two-dimensional (2D) pattern of illustrating the enormous improvement that X-rays transmitted through the volume of the has occurred in both technology and technique. breast onto an image receptor. Breast cancer is Breast positioning, penetration of the tissue, and detected radiographically on the basis of four contrast are excellent, allowing visualization of major signs: a mass density with specific shape a small area of ductal carcinoma in situ (DCIS) and border characteristics, microcalcifications, seen on the basis of microcalcifications, and, architectural distortions, and asymmetries more importantly, providing the opportunity to between the radiological appearance of the left detect an immediately adjacent high-grade inva- and right breast (Kopans, 2006). These signs sive cancer 1.7 mm in diameter. are often very subtle, and in order for them to Excellent image quality is an essential compo- be detected accurately and when the cancer is at nent but not, on its own, a sufficient component the smallest detectable size, the technical image to ensure a high level of accuracy in cancer detec- quality of the mammograms must be excellent tion.
    [Show full text]
  • Contrast‐Enhanced Ultrasound Bibliography General Principles 1
    Contrast‐enhanced Ultrasound Bibliography General Principles 1.Claudon M et al. Guidlines and Good Clinical Practice Recommendations for Contrast Ultrasound (CEUS)‐Update 2008 Ultraschall in Med 2008;29:28‐44 2.Cosgrove. D. Editorial. Eur Radiol Suppl (2004).14[Suppl 8]:1‐3 3.Burns PN, Wilson,S. Microbubble Contrast for Radiological Imaging:1 Principles. Ultrasound Quarterly 2006;22:5‐11 4.Wilson S et al. Contrast‐enhanced Ultrasound: What is the Evidence and What Are the Obstacles? AJR. 2009;193:55‐60 Safety 1.ter Haar GR. Ultrasonic Contrast Agents: Safety Considerations Reviewed. Eur J Radiol 2002;41:217‐221 2. Main MI. Ultrasound Contrast Agent Safety. J Am Coll Cardiol Img 2009:2:1057‐ 1059 3. Pisaglia F et al. SonoVue in Abdominal applications: Retrospective Analysis of 23188 Investigations. Ultrasound in Med and Biol.2006;32:1369‐1375 4. Hynynen K et al. The Threshold for Brain Damage in Rabbits Induced By Bursts of Ultrasound in the Presence of an Ultrasound Contrast Agent (Optison). Ultrasound in Med and Biol;29:473‐481 Voiding Urosonography 1.Darge K. et al. Reflux in Young Patients: Comparison of Voiding US of the Bladder and Retrovesical Space with Echo Enhancement versus Voiding Cystourethrography for Diagnosis. Radiology 1999;210:201‐207 2.Radmayr C et al. Contrast Enhanced Reflux Sonography in Children: A Comparison to Standard Radiological Imaging J Urol 2002;167:1428‐30 Liver Lesion Characterization 1.Bolondi L et al. New Perspectives for the Use of Contrast‐Enhanced Liver Ultrasound in Clinical Practice. Digestive and Liver Disease 2007;39:187‐195 2.Berry J, Sidu, P.
    [Show full text]
  • Radiation Protection Guidance for Diagnostic X Rays
    Disclaimer - For assistance accessing this document or additional information, please contact [email protected]. EPA 520/4-76-019 FEDERAL GUIDANCE REPORT NO. 9 RADIATION PROTECTION GUIDANCE FOR DIAGNOSTIC X RAYS ENVIRONMENTAL PROTECTION AGENCY INTERAGENCY WORKING GROUP ON MEDICAL RADIATION FEDERAL GUIDANCE REPORT NO. 9 RADIATION PROTECTION GUIDANCE FOR DIAGNOSTIC X RAYS Interagency Working Group on Medical Radiation U.S. Environmental Protection Agency Washington, D.C. 20460 October 1976 PREFACE The authority of the Federal Radiation Council to provide radiation protection guidance was transferred to the Environmental Protection Agency on December 2, 1970, by Reorganization Plan No. 3. Prior to this transfer, the Federal Radiation Council developed reports which provided the basis for guidance recommended to the President for use by Federal agencies in developing standards for a wide range of radiation exposure circumstances. This report, which was prepared in cooperation with an Interagency Working Group on Medical Radiation formed on July 5, 1974, constitutes a similar objective to provide the basis for recommendations to reduce unnecessary radiation exposure due to medical uses of diagnostic x rays. The Interagency Working Group developed its recommendations with the help of two subcommittees. The Subcommittee on Prescription of Exposure to X rays examined factors to eliminate clinically unproductive examinations and the Subcommittee on Technic of Exposure Prevention examined factors to assure the use of optimal technic in performing x-ray examinations. Both subcommittees also considered the importance of appropriate and properly functioning equipment in producing radiographs of the required diagnostic quality with minimal exposure. Reports by these subcommittees were made available for public comment.
    [Show full text]
  • Nuclear Medicine for Medical Students and Junior Doctors
    NUCLEAR MEDICINE FOR MEDICAL STUDENTS AND JUNIOR DOCTORS Dr JOHN W FRANK M.Sc, FRCP, FRCR, FBIR PAST PRESIDENT, BRITISH NUCLEAR MEDICINE SOCIETY DEPARTMENT OF NUCLEAR MEDICINE, 1ST MEDICAL FACULTY, CHARLES UNIVERSITY, PRAGUE 2009 [1] ACKNOWLEDGEMENTS I would very much like to thank Prof Martin Šámal, Head of Department, for proposing this project, and the following colleagues for generously providing images and illustrations. Dr Sally Barrington, Dept of Nuclear Medicine, St Thomas’s Hospital, London Professor Otakar Bělohlávek, PET Centre, Na Homolce Hospital, Prague Dr Gary Cook, Dept of Nuclear Medicine, Royal Marsden Hospital, London Professor Greg Daniel, formerly at Dept of Veterinary Medicine, University of Tennessee, currently at Virginia Polytechnic Institute and State University (Virginia Tech), Past President, American College of Veterinary Radiology Dr Andrew Hilson, Dept of Nuclear Medicine, Royal Free Hospital, London, Past President, British Nuclear Medicine Society Dr Iva Kantorová, PET Centre, Na Homolce Hospital, Prague Dr Paul Kemp, Dept of Nuclear Medicine, Southampton University Hospital Dr Jozef Kubinyi, Institute of Nuclear Medicine, 1st Medical Faculty, Charles University Dr Tom Nunan, Dept of Nuclear Medicine, St Thomas’s Hospital, London Dr Kathelijne Peremans, Dept of Veterinary Medicine, University of Ghent Dr Teresa Szyszko, Dept of Nuclear Medicine, St Thomas’s Hospital, London Ms Wendy Wallis, Dept of Nuclear Medicine, Charing Cross Hospital, London Copyright notice The complete text and illustrations are copyright to the author, and this will be strictly enforced. Students, both undergraduate and postgraduate, may print one copy only for personal use. Any quotations from the text must be fully acknowledged. It is forbidden to incorporate any of the illustrations or diagrams into any other work, whether printed, electronic or for oral presentation.
    [Show full text]
  • Future of Breast Elastography
    Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
    [Show full text]
  • Amorphous Lead Oxide (A-Pbo): Suppression of Signal Lag Via Engineering of the Layer Structure Received: 12 June 2017 O
    www.nature.com/scientificreports OPEN Amorphous lead oxide (a-PbO): suppression of signal lag via engineering of the layer structure Received: 12 June 2017 O. Semeniuk1,2, O. Grynko1,2, G. Juska3 & A. Reznik2,4 Accepted: 25 September 2017 Presence of a signal lag is a bottle neck of performance for many non-crystalline materials, considered Published: xx xx xxxx for dynamic radiation sensing. Due to inadequate lag-related temporal performance, polycrystalline layers of CdZnTe, PbI2, HgI2 and PbO are not practically utilized, despite their superior X-ray sensitivity and low production cost (even for large area detectors). In the current manuscript, we show that a technological step to replace nonhomogeneous disorder in polycrystalline PbO with homogeneous amorphous PbO structure suppresses signal lag and improves time response to X-ray irradiation. In addition, the newly developed amorphous lead oxide (a-PbO) possesses superior X-ray sensitivity in terms of electron-hole pair creation energy W± in comparison with amorphous selenium – currently the only photoconductor used as an X-ray-to-charge transducer in the state-of-the-art direct conversion X-ray medical imaging systems. The proposed advances of the deposition process are low cost, easy to implement and with certain customization might potentially be applied to other materials, thus paving the way to their wide-range commercial use. Amorphous and polycrystalline modifcations of wide band gap semiconductors are of paramount importance in modern electronics, since they allow large device area production at low cost. However, the transition from crystalline to non-crystalline materials is technologically challenging since structural disorder may lead to degra- dation of the material performance.
    [Show full text]
  • Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
    Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
    [Show full text]
  • Radiographic Diagnostic Aids: a Review © 2019 IJADS Received: 01-02-2019 Dr
    International Journal of Applied Dental Sciences 2019; 5(2): 271-276 ISSN Print: 2394-7489 ISSN Online: 2394-7497 IJADS 2019; 5(2): 271-276 Radiographic diagnostic Aids: A review © 2019 IJADS www.oraljournal.com Received: 01-02-2019 Dr. Panna Mangat, Dr. Anil K Tomer, Dr. Afnan Ajaz Raina, Dr. Faizan Accepted: 03-03-2019 Bin Ayub, Dr. Akankshita Behera, Dr. Nitish Mittal, Dr. Megna Bhatt Dr. Panna Mangat Professor, Department of Conservative and Dr. Ayush Tyagi Dentistry & Endodontics D.J. College of Dental Sciences and Research, Modinagar, Ghaziabad, Uttar Pradesh, Abstract India Presently diagnosis has shown a major growth in the field of Endodontics. Newer technologies have evolved in a way that human elements are being enriched in a much better way to ensure proper and Dr. Anil K Tomer Professor and Head, Department of correct diagnosis. Therefore, for a successful diagnostician, a necessity arises to keep abreast of all the Conservative Dentistry & Endodontics new methods for correct diagnosis and treatment. The aim of this review therefore is to assess the D.J. College of Dental Sciences and usefulness of some radiographic diagnostic aids and techniques used in endodontic therapy to make the Research, Modinagar, Ghaziabad, Uttar correct pulpal diagnosis. Pradesh, India Dr. Afnan Ajaz Raina Keywords: Radiographic diagnostic, aids, endodontics Post Graduate Student, Department of Conservative Dentistry & Endodontics D.J. College of Dental Sciences and Introduction Research, Modinagar, Ghaziabad, Uttar Pradesh, India Diagnosis is arguably the most critical component of all dental treatment, and Endodontics is no exception. Stedman’s Medical Dictionary describes clinical diagnosis as ‘‘the Dr.
    [Show full text]
  • Nuclear Pharmacy Quick Sample
    12614-01_CH01-rev3.qxd 10/25/11 10:56 AM Page 1 CHAPTER 1 Radioisotopes Distribution for Not 1 12614-01_CH01-rev3.qxd 10/25/1110:56AMPage2 2 N TABLE 1-1 Radiopharmaceuticals Used in Nuclear Medicine UCLEAR Chemical Form and Typical Dosage P Distribution a b HARMACY Radionuclide Dosage Form Use (Adult ) Route Carbon C 11 Carbon monoxide Cardiac: Blood volume measurement 60–100 mCi Inhalation Carbon C 11 Flumazenil injection Brain: Benzodiazepine receptor imaging 20–30 mCi IV Q UICK Carbon C 11 Methionine injection Neoplastic disease evaluation in brain 10–20 mCi IV R Carbon C 11 forRaclopride injection Brain: Dopamine D2 receptor imaging 10–15 mCi IV EFERENCE Carbon C 11 Sodium acetate injection Cardiac: Marker of oxidative metabolism 12–40 mCi IV Carbon C 14 Urea Diagnosis of Helicobacter pylori infection 1 µCi PO Chromium Cr 51 Sodium chromate injection Labeling red blood cells (RBCs) for mea- 10–80 µCi IV suring RBC volume, survival, and splenic sequestration Cobalt Co 57 Cyanocobalamin capsules Diagnosis of pernicious anemia and 0.5 µCi PO Not defects of intestinal absorption Fluorine F 18 Fludeoxyglucose injection Glucose utilization in brain, cardiac, and 10–15 mCi IV neoplastic disease Fluorine F 18 Fluorodopa injection Dopamine neuronal decarboxylase activity 4–6 mCi IV in brain Fluorine F 18 Sodium fluoride injection Bone imaging 10 mCi IV Gallium Ga 67 Gallium citrate injection Hodgkin’s disease, lymphoma 8–10 mCi IV Acute inflammatory lesions 5 mCi IV Indium In 111 Capromab pendetide Metastatic imaging in patients with biopsy-
    [Show full text]
  • ACR–SPR Practice Parameter for the Performance of Voiding
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2019 (Resolution 10)* ACR–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF FLUOROSCOPIC AND SONOGRAPHIC VOIDING CYSTOURETHROGRAPHY IN CHILDREN PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • Breast Ultrasound Accreditation Program Requirements
    Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]